In the last 12 months, insiders at enVVeno Medical Corp ($NVNO) filed 34 transactions with the SEC: 5 open-market purchases totaling $330,888 and 4 sales totaling $59,260. Net insider sentiment: net buying.
enVVeno Medical Corp operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Duhay Francis (Director) — 7 transactions totaling $257,422
- Alavi Hamed (Chief Technology Officer) — 6 transactions totaling $81,757
- BERMAN ROBERT ANDREW (Chief Executive Officer) — 4 transactions totaling $30,600
- Jenusaitis Matthew (Director) — 4 transactions totaling $24,339
- Shrivastava Sanjay (Director) — 4 transactions totaling $15,660
View all SEC Filings for enVVeno Medical Corp (NVNO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Duhay Francis | Director | S | Common Stock | 140 | $11.52 | 2,502.0000 | 20,286,000 | 5.30% | 0.00% |
| Dec. 16, 2025 | BERMAN ROBERT ANDREW | Chief Executive Officer | J | Restricted Stock Units | 200000 | $0.00 | 0.0000 | 20,286,000 | 100.00% | 0.99% |
| Dec. 16, 2025 | Glickman Marc H. | SVP & Chief Medical Officer | J | Restricted Stock Units | 100000 | $0.00 | 0.0000 | 20,286,000 | 100.00% | 0.49% |
| Dec. 16, 2025 | Alavi Hamed | Chief Technology Officer | J | Restricted Stock Units | 50000 | $0.00 | 0.0000 | 20,286,000 | 100.00% | 0.25% |
| Dec. 11, 2025 | Gray Robert | Director | A | Stock Options | 135883 | $0.00 | 135,883.0000 | 20,286,000 | 9999.99% | 0.67% |
| Dec. 11, 2025 | Shrivastava Sanjay | Director | A | Stock Options | 135883 | $0.00 | 135,883.0000 | 20,286,000 | 9999.99% | 0.67% |
| Dec. 11, 2025 | Jenusaitis Matthew | Director | A | Stock Options | 135883 | $0.00 | 135,883.0000 | 20,286,000 | 9999.99% | 0.67% |
| Dec. 11, 2025 | Duhay Francis | Director | A | Stock Options | 135883 | $0.00 | 135,883.0000 | 20,286,000 | 9999.99% | 0.67% |
| Dec. 11, 2025 | Duhay Francis | Director | S | Common Stock | 4900 | $0.36 | 92,544.0000 | 20,286,000 | 5.03% | 0.02% |
| Sept. 15, 2025 | Duhay Francis | Director | S | Common Stock | 4900 | $0.83 | 97,444.0000 | 17,142,000 | 4.79% | 0.03% |
| May 19, 2025 | Bright Jennifer | Chief Financial Officer | A | Stock Options | 350000 | $0.00 | 350,000.0000 | 17,142,000 | 9999.99% | 2.04% |
| Dec. 31, 2024 | Duhay Francis | Director | P | Common Stock | 81433 | $3.07 | 102,344.0000 | 16,067,000 | 389.43% | 0.51% |
| Dec. 31, 2024 | Gray Robert | Director | P | Common Stock | 3500 | $2.94 | 11,155.0000 | 16,067,000 | 45.72% | 0.02% |
| Dec. 24, 2024 | Shrivastava Sanjay | Director | P | Common Stock | 5400 | $2.90 | 9,288.0000 | 16,067,000 | 138.89% | 0.03% |
| Dec. 19, 2024 | Jenusaitis Matthew | Director | P | Common Stock | 9620 | $2.53 | 16,545.0000 | 16,067,000 | 138.92% | 0.06% |
| Dec. 18, 2024 | Glickman Marc H. | SVP & Chief Medical Officer | A | Stock Options | 75000 | $0.00 | 75,000.0000 | 16,067,000 | 9999.99% | 0.47% |
| Dec. 18, 2024 | Jenusaitis Matthew | Director | A | Stock Options | 19752 | $0.00 | 19,752.0000 | 16,067,000 | 9999.99% | 0.12% |
| Dec. 18, 2024 | Alavi Hamed | Chief Technology Officer | A | Stock Options | 75000 | $0.00 | 75,000.0000 | 16,067,000 | 9999.99% | 0.47% |
| Dec. 18, 2024 | Shrivastava Sanjay | Director | A | Stock Options | 19752 | $0.00 | 19,752.0000 | 16,067,000 | 9999.99% | 0.12% |
| Dec. 18, 2024 | Gray Robert | Director | A | Stock Options | 19752 | $0.00 | 19,752.0000 | 16,067,000 | 9999.99% | 0.12% |
| Dec. 18, 2024 | Duhay Francis | Director | A | Stock Options | 19752 | $0.00 | 19,752.0000 | 16,067,000 | 9999.99% | 0.12% |
| Dec. 18, 2024 | BERMAN ROBERT ANDREW | Chief Executive Officer | A | Stock Options | 200000 | $0.00 | 200,000.0000 | 16,067,000 | 9999.99% | 1.24% |
| Dec. 19, 2024 | BERMAN ROBERT ANDREW | Chief Executive Officer | P | Common Stock | 12000 | $2.55 | 222,236.0000 | 16,067,000 | 5.71% | 0.07% |
| March 13, 2024 | Alavi Hamed | Chief Technology Officer | M | Stock Options | 8334 | $0.00 | 91,666.0000 | 12,301,000 | 8.33% | 0.07% |
| March 13, 2024 | Alavi Hamed | Chief Technology Officer | S | Common Stock | 8334 | $6.22 | 0.0000 | 12,301,000 | 100.00% | 0.07% |
| March 13, 2024 | Alavi Hamed | Chief Technology Officer | M | Common Stock | 8334 | $3.59 | 8,334.0000 | 12,301,000 | 9999.99% | 0.07% |
| Dec. 5, 2023 | Jenusaitis Matthew | Director | A | Stock Options | 13856 | $0.00 | 13,856.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Alavi Hamed | Chief Technology Officer | A | Stock Options | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Glickman Marc H. | SVP & Chief Medical Officer | A | Stock Options | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Shrivastava Sanjay | Director | A | Stock Options | 13856 | $0.00 | 13,856.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Gray Robert | Director | A | Stock Options | 13856 | $0.00 | 13,856.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Duhay Francis | Director | A | Stock Options | 13856 | $0.00 | 13,856.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | BERMAN ROBERT ANDREW | Chief Executive Officer | A | Stock Options | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 5, 2023 | Glynn Craig | Chief Financial Officer | A | Stock Options | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |